RxDoctor Payments Data

Michael Levitz, DO

Internal Medicine · Newburyport, MANPI 1417498379

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 35th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$526,776
Medicare patients
1,420
Services billed
4,251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban474$99,316
XifaxanRifaximin26$45,875
XareltoRivaroxaban173$35,236
TrulicityDulaglutide44$29,739
TeflaroCeftaroline Fosamil Acetate17$24,085
JardianceEmpagliflozin69$18,947
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$15,025
MyrbetriqMirabegron56$12,901
JanuviaSitagliptin Phosphate81$11,429
Mirtazapine299$9,652
Divalproex Sodium190$9,509
Atorvastatin Calcium598$7,590
Trazodone Hcl749$6,826
Advair HfaFluticasone Propion/Salmeterol15$6,042
EntrestoSacubitril/Valsartan18$5,495

Paid to pharmacies, not to this prescriber.

Other internal medicine in Newburyport

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →